Xenon Pharmaceuticals (XENE) News Today $41.63 -0.54 (-1.28%) Closing price 10/17/2025 04:00 PM EasternExtended Trading$41.64 +0.00 (+0.01%) As of 10/17/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock XENE Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Receives Consensus Recommendation of "Moderate Buy" from AnalystsOctober 18 at 2:25 AM | americanbankingnews.comXenon Pharmaceuticals Inc. (NASDAQ:XENE) Given Consensus Recommendation of "Moderate Buy" by BrokeragesOctober 18 at 2:23 AM | marketbeat.comXenon Pharmaceuticals appoints Tucker Kelly as Chief Financial OfficerOctober 16 at 2:17 PM | msn.comXenon Pharmaceuticals Appoints Tucker Kelly as CFO to Drive Commercialization EffortsOctober 16 at 9:31 AM | tipranks.comXenon Pharmaceuticals Inc. Appoints Tucker Kelly as Chief Financial Officer to Advance Commercialization of AzetukalnerOctober 16 at 8:51 AM | quiverquant.comQXenon Announces Appointment of Tucker Kelly as Chief Financial OfficerOctober 16 at 8:30 AM | globenewswire.comXenon (XENE) Receives a Buy from JefferiesOctober 16 at 4:15 AM | theglobeandmail.comXenon Pharmaceuticals (NASDAQ:XENE) Earns "Sell (D-)" Rating from Weiss RatingsOctober 16 at 2:07 AM | americanbankingnews.comInvestors Buy High Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE)October 16 at 2:31 AM | marketbeat.comAberdeen Group plc Boosts Position in Xenon Pharmaceuticals Inc. $XENEOctober 15, 2025 | marketbeat.comXenon Pharmaceuticals (NASDAQ:XENE) Given "Sell (D-)" Rating at Weiss RatingsOctober 14, 2025 | marketbeat.comXenon Pharmaceuticals (XENE): Exploring Valuation After Recent Share Price MomentumOctober 12, 2025 | finance.yahoo.comWhat is Bloom Burton's Forecast for XENE FY2025 Earnings?October 11, 2025 | americanbankingnews.comResearch Analysts Issue Forecasts for XENE FY2025 EarningsOctober 10, 2025 | marketbeat.comXenon Pharmaceuticals' (XENE) "Outperform" Rating Reiterated at William BlairOctober 10, 2025 | americanbankingnews.comBrokers Offer Predictions for XENE FY2026 EarningsOctober 8, 2025 | marketbeat.comBloom Burton Upgrades Xenon Pharmaceuticals (NASDAQ:XENE) to "Strong-Buy"October 8, 2025 | marketbeat.comChardan Capital Maintains Xenon Pharmaceuticals (XENE) Buy RecommendationOctober 7, 2025 | msn.comXenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)October 7, 2025 | financialpost.comFXenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)October 7, 2025 | globenewswire.comXenon Pharmaceuticals' (XENE) Outperform Rating Reiterated at William BlairOctober 7, 2025 | marketbeat.comXenon Pharmaceuticals (NASDAQ:XENE) Receives "Buy" Rating from Chardan CapitalOctober 7, 2025 | marketbeat.comXenon Pharmaceuticals Inc. (XENE) Nav1.7 And Kv7 Programs Investor Webinar TranscriptOctober 6, 2025 | seekingalpha.comXenon Pharmaceuticals Inc. $XENE Shares Purchased by J. Safra Sarasin Holding AGOctober 4, 2025 | marketbeat.comHighMark Wealth Management LLC Has $817,000 Holdings in Xenon Pharmaceuticals Inc. $XENEOctober 3, 2025 | marketbeat.comXenon Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:XENE)October 2, 2025 | marketbeat.comInsider Selling: Xenon Pharmaceuticals (NASDAQ:XENE) CEO Sells 25,000 Shares of StockOctober 1, 2025 | marketbeat.comStocks Generating Improved Relative Strength: Xenon PharmaceuticalsOctober 1, 2025 | msn.comXenon Pharmaceuticals (NASDAQ:XENE) Stock Price Passes Above 50-Day Moving Average - What's Next?October 1, 2025 | marketbeat.comXenon Announces Upcoming Investor Webinar to Discuss Early-Stage Ion Channel Programs for the Potential Treatment of PainSeptember 25, 2025 | globenewswire.comAssenagon Asset Management S.A. Increases Holdings in Xenon Pharmaceuticals Inc. $XENESeptember 23, 2025 | marketbeat.comVoya Investment Management LLC Has $1.61 Million Stake in Xenon Pharmaceuticals Inc. $XENESeptember 23, 2025 | marketbeat.comXenon Pharmaceuticals Inc. (NASDAQ:XENE) Given Consensus Rating of "Buy" by BrokeragesSeptember 23, 2025 | marketbeat.comHarbor Capital Advisors Inc. Sells 26,555 Shares of Xenon Pharmaceuticals Inc. $XENESeptember 19, 2025 | marketbeat.comInvestors Purchase High Volume of Xenon Pharmaceuticals Put Options (NASDAQ:XENE)September 18, 2025 | marketbeat.comAlliancebernstein L.P. Lowers Holdings in Xenon Pharmaceuticals Inc. $XENESeptember 9, 2025 | marketbeat.comParkman Healthcare Partners LLC Decreases Stake in Xenon Pharmaceuticals Inc. $XENESeptember 8, 2025 | marketbeat.comAlyeska Investment Group L.P. Purchases 78,390 Shares of Xenon Pharmaceuticals Inc. $XENESeptember 7, 2025 | marketbeat.comWells Fargo & Company Reiterates Overweight Rating for Xenon Pharmaceuticals (NASDAQ:XENE)September 5, 2025 | marketbeat.comAlly Bridge Group NY LLC Trims Position in Xenon Pharmaceuticals Inc. $XENESeptember 5, 2025 | marketbeat.comXenon Pharmaceuticals Inc. $XENE Shares Acquired by Adage Capital Partners GP L.L.C.September 5, 2025 | marketbeat.comInvestors Buy High Volume of Xenon Pharmaceuticals Put Options (NASDAQ:XENE)September 5, 2025 | marketbeat.comXenon Pharmaceuticals' (XENE) Outperform Rating Reiterated at Royal Bank Of CanadaSeptember 4, 2025 | marketbeat.comADAR1 Capital Management LLC Has $4.28 Million Holdings in Xenon Pharmaceuticals Inc. $XENESeptember 4, 2025 | marketbeat.comFirst Light Asset Management LLC Sells 532,676 Shares of Xenon Pharmaceuticals Inc. $XENESeptember 4, 2025 | marketbeat.comXenon Pharmaceuticals Inc. $XENE is Vestal Point Capital LP's 9th Largest PositionSeptember 4, 2025 | marketbeat.comBirchview Capital LP Has $705,000 Stake in Xenon Pharmaceuticals Inc. $XENESeptember 4, 2025 | marketbeat.comMPM Bioimpact LLC Raises Stock Holdings in Xenon Pharmaceuticals Inc. $XENESeptember 4, 2025 | marketbeat.comBaker BROS. Advisors LP Sells 646,271 Shares of Xenon Pharmaceuticals Inc. $XENESeptember 4, 2025 | marketbeat.comXenon Pharmaceuticals assumed with an Overweight at Wells FargoSeptember 3, 2025 | msn.com Get Xenon Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for XENE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. XENE Media Mentions By Week XENE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XENE News Sentiment▼0.600.48▲Average Medical News Sentiment XENE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XENE Articles This Week▼137▲XENE Articles Average Week Get the Latest News and Ratings for XENE and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Xenon Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Dr. Reddy's Laboratories News Viatris News Roivant Sciences News BridgeBio Pharma News Moderna News QIAGEN News Elanco Animal Health News Verona Pharma PLC American Depositary Share News Revolution Medicines News Abivax News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XENE) was last updated on 10/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xenon Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xenon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XENE Stock Alerts